February 14, 2019
Jamie Blundell, President & COO is pleased to provide the following update Next Green Wave, one of CGOC’s public holdings:
Next Green Wave announced today that it has entered into a memorandum of understanding “MOU” to take a strategic investment in Organic Medical Growth OMG3 INC. (“OMG”), a Canadian based company operating a wholly owned Colombian subsidiary called Proymed S.A.S “Proymed”. Proymed is a medical cannabis company focused on producing and commercializing non-psychoactive (CBD) products derived from medicinal and industrial cannabis. Proymed is finalizing its transformation and psychoactive (THC) licenses in Colombia as well as finalizing international distribution agreements.
Subject to completion of a definitive agreement and applicable regulatory approvals including the approval of the Canadian Securites Exchange, Next Green Wave will have access to the Colombia cannabis market which has an estimated potential to supply 6 million patients.
To read the full release from Next Green Wave click here.
For more information on the Columbian Cannabis market click here.
For further information please contact Cannabis Growth Opportunity Corporation:
|Website: www.cgocorp.com||Investor Relations Email: email@example.com|
About Next Green Wave
Next Green Wave is a vertically integrated seed-to-consumer premium medicinal and recreational cannabis company operating in California, one of the world’s largest cannabis markets. The Company’s central operations are in the city of Coalinga which is located between two major markets of San Francisco and Los Angeles and has been awarded licenses for nursery, cultivation, extraction, and distribution. Next Green Wave is led by an experienced management team with a focus on international brand development. The Company currently owns over 15 acres of cannabis-zoned development land and is nearing completion on its first proprietary engineered 35,000 ft² facility.
For more information visit www.nextgreenwave.com/investors